Truvian Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 119

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $74M

  • Investors
  • 19

Truvian General Information

Description

Developer of an automated blood testing and diagnostic technology designed to deliver a convenient and affordable alternative to off-site labs. The company's technology combines clinical chemistries, immunoassays, and hematology assays all within one instrument, in a single run and provides lab-accurate results in less time for a suite of health tests, enabling healthcare professionals to get access to comprehensive, easy-to-understand lab test reports and insights while also making routine health testing suitable and reasonable.

Contact Information

Formerly Known As
Salveo Dx
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10300 Campus Point Drive
  • Suite 190
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 10300 Campus Point Drive
  • Suite 190
  • San Diego, CA 92121
  • United States
+1 (858)

Truvian Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Truvian Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series D) 17-Jul-2024 $74M Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Later Stage VC (Series C) 01-Jul-2023 Completed Generating Revenue
6. Debt - General 14-Sep-2021 Completed Generating Revenue
5. Later Stage VC (Series C) 19-Feb-2021 Completed Generating Revenue
4. Debt - PPP 28-Apr-2020 Completed Generating Revenue
3. Early Stage VC (Series B) 30-May-2019 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Jan-2019 $17.3M $19.3M Completed Generating Revenue
1. Early Stage VC 12-Oct-2015 $2M $2M Completed Startup
To view Truvian’s complete valuation and funding history, request access »

Truvian Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D-2
Series D-1
Series C
Series B
Series A 857,512,088 $0.000100 $0.13 $0.02 $0.02 1x $0.02 17.98%
Seed 333,333,300 $0.000100 $0.05 $0.01 $0.01 1x $0.01 6.99%
To view Truvian’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Truvian Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an automated blood testing and diagnostic technology designed to deliver a convenient and affordable altern
Diagnostic Equipment
San Diego, CA
119 As of 2025

Neuchatel, Switzerland
 

Tel Aviv, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Truvian Competitors (5)

One of Truvian’s 5 competitors is 1Drop, a Formerly VC-backed company based in Neuchatel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
1Drop Formerly VC-backed Neuchatel, Switzerland
Sight Diagnostics Venture Capital-Backed Tel Aviv, Israel
Genalyte Venture Capital-Backed San Diego, CA
Autogenomics Formerly VC-backed Carlsbad, CA
LetsGetChecked Venture Capital-Backed Dublin, Ireland
You’re viewing 5 of 5 competitors. Get the full list »

Truvian Patents

Truvian Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4520432-A1 Optical multianalyte detection Pending 08-Sep-2023
US-12287321-B2 Optical multianalyte detection Active 08-Sep-2023
US-20250085271-A1 Optical multianalyte detection Active 08-Sep-2023
US-20250369952-A1 Optical multianalyte detection Pending 08-Sep-2023
WO-2025054058-A1 Optical multianalyte detection Inactive 08-Sep-2023 G01N33/492
To view Truvian’s complete patent history, request access »

Truvian Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Truvian Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
HSBC Ventures Corporate Venture Capital Minority
Fanjul Capital PE/Buyout Minority
Medical Excellence Capital Venture Capital Minority
Spring Creek Partners Family Office Minority
General Catalyst Venture Capital Minority
You’re viewing 5 of 19 investors. Get the full list »

Truvian FAQs

  • When was Truvian founded?

    Truvian was founded in 2015.

  • Where is Truvian headquartered?

    Truvian is headquartered in San Diego, CA.

  • What is the size of Truvian?

    Truvian has 119 total employees.

  • What industry is Truvian in?

    Truvian’s primary industry is Diagnostic Equipment.

  • Is Truvian a private or public company?

    Truvian is a Private company.

  • What is the current valuation of Truvian?

    The current valuation of Truvian is .

  • What is Truvian’s current revenue?

    The current revenue for Truvian is .

  • How much funding has Truvian raised over time?

    Truvian has raised $294M.

  • Who are Truvian’s investors?

    HSBC Ventures, Fanjul Capital, Medical Excellence Capital, Spring Creek Partners, and General Catalyst are 5 of 19 investors who have invested in Truvian.

  • Who are Truvian’s competitors?

    1Drop, Sight Diagnostics, Genalyte, Autogenomics, and LetsGetChecked are competitors of Truvian.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process